Role of RNA structures present at the 3′UTR of dengue virus on translation, RNA synthesis, and viral replication

Alvarez, 2005, Long-range RNA–RNA interactions circularize the dengue virus genome, J. Virol., 79, 6631, 10.1128/JVI.79.11.6631-6643.2005 Blaney, 2004, Vaccine candidates derived from a novel infectious cDNA clone of an American genotype dengue virus type 2, BMC Infect. Dis., 4, 39, 10.1186/1471-2334-4-39 Brinton, 1986, The 3′-nucleotides of flavivirus genomic RNA form a conserved secondary structure, Virology, 153, 113, 10.1016/0042-6822(86)90012-7 Cologna, 2003, American genotype structures decrease dengue virus output from human monocytes and dendritic cells, J. Virol., 77, 3929, 10.1128/JVI.77.7.3929-3938.2003 Durbin, 2001, Attenuation and immunogenicity in humans of a live dengue virus type-4 vaccine candidate with a 30 nucleotide deletion in its 3′-untranslated region, Am. J. Trop. Med. Hyg., 65, 405, 10.4269/ajtmh.2001.65.405 Elghonemy, 2005, The majority of the nucleotides in the top loop of the genomic 3′ terminal stem loop structure are cis-acting in a West Nile virus infectious clone, Virology, 331, 238, 10.1016/j.virol.2004.11.008 Gubler, 1998, Dengue and dengue hemorrhagic fever, Clin. Microbiol. Rev., 11, 480, 10.1128/CMR.11.3.480 Gubler, 1978, Epidemiologic, clinical, and virologic observations on dengue in the Kingdom of Tonga, Am. J. Trop. Med. Hyg., 27, 581, 10.4269/ajtmh.1978.27.581 Hahn, 1987, Conserved elements in the 3′ untranslated region of flavivirus RNAs and potential cyclization sequences, J. Mol. Biol., 198, 33, 10.1016/0022-2836(87)90455-4 Hanley, 2004, Introduction of mutations into the non-structural genes or 3′ untranslated region of an attenuated dengue virus type 4 vaccine candidate further decreases replication in rhesus monkeys while retaining protective immunity, Vaccine, 22, 3440, 10.1016/j.vaccine.2004.02.031 Holden, 2004, Enhancement of dengue virus translation: role of the 3′ untranslated region and the terminal 3′ stem–loop domain, Virology, 329, 119, 10.1016/j.virol.2004.08.004 Khromykh, 1998, trans-Complementation of flavivirus RNA polymerase gene NS5 by using Kunjin virus replicon-expressing BHK cells, J. Virol., 72, 7270, 10.1128/JVI.72.9.7270-7279.1998 Khromykh, 2001, Essential role of cyclization sequences in flavivirus RNA replication, J. Virol., 75, 6719, 10.1128/JVI.75.14.6719-6728.2001 Khromykh, 2003, Significance in replication of the terminal nucleotides of the flavivirus genome, J. Virol., 77, 10623, 10.1128/JVI.77.19.10623-10629.2003 Kinney, 1997, Construction of infectious cDNA clones for dengue 2 virus: strain 16681 and its attenuated vaccine derivative, strain PDK-53, Virology, 230, 300, 10.1006/viro.1997.8500 Kong, 2002, Cytoplasmic expression of mRNAs containing the internal ribosome entry site and 3′ noncoding region of hepatitis C virus: effects of the 3′ leader on mRNA translation and mRNA stability, J. Virol., 76, 12457, 10.1128/JVI.76.24.12457-12462.2002 Leitmeyer, 1999, Dengue virus structural differences that correlate with pathogenesis, J. Virol., 73, 4738, 10.1128/JVI.73.6.4738-4747.1999 Lo, 2003, Functional analysis of mosquito-borne flavivirus conserved sequence elements within 3′ untranslated region of West Nile virus by use of a reporting replicon that differentiates between viral translation and RNA replication, J. Virol., 77, 10004, 10.1128/JVI.77.18.10004-10014.2003 Mackenzie, 1998, Subcellular localization and some biochemical properties of the flavivirus Kunjin nonstructural proteins NS2A and NS4A, Virology, 245, 203, 10.1006/viro.1998.9156 Markoff, 2003, 5′ and 3′ NCRs in Flavivirus RNA, vol. 60 Men, 1996, Dengue type 4 virus mutants containing deletions in the 3′ noncoding region of the RNA genome: analysis of growth restriction in cell culture and altered viremia pattern and immunogenicity in rhesus monkeys, J. Virol., 70, 3930, 10.1128/JVI.70.6.3930-3937.1996 Nomaguchi, 2004, Requirements for West Nile virus (−)-and (+)-strand subgenomic RNA synthesis in vitro by the viral RNA-dependent RNA polymerase expressed in Escherichia coli, J. Biol. Chem., 279, 12141, 10.1074/jbc.M310839200 Pang, 2001, Development of Dengue virus type 2 replicons capable of prolonged expression in host cells, BMC Microbiol., 1, 18, 10.1186/1471-2180-1-18 Proutski, 1997, Secondary structure of the 3′ untranslated region of flaviviruses: similarities and differences, Nucleic Acids Res., 25, 1194, 10.1093/nar/25.6.1194 Proutski, 1999, Biological consequences of deletions within the 3′-untranslated region of flaviviruses may be due to rearrangements of RNA secondary structure, Virus Res., 64, 107, 10.1016/S0168-1702(99)00079-9 Rauscher, 1997, Secondary structure of the 3′-noncoding region of flavivirus genomes: comparative analysis of base pairing probabilities, RNA, 3, 779 Rice, 2001, Flaviviridae: The Viruses and Their Replication, vol. 1 Rico-Hesse, 1997, Origins of dengue type 2 viruses associated with increased pathogenicity in the Americas, Virology, 230, 244, 10.1006/viro.1997.8504 Ryan, 1994, Foot-and-mouth disease virus 2A oligopeptide mediated cleavage of an artificial polyprotein, EMBO J., 13, 928, 10.1002/j.1460-2075.1994.tb06337.x Shurtleff, 2001, Genetic variation in the 3′ non-coding region of dengue viruses, Virology, 281, 75, 10.1006/viro.2000.0748 Tilgner, 2004, Structure and function of the 3′ terminal six nucleotides of the West Nile virus genome in viral replication, J. Virol., 78, 8159, 10.1128/JVI.78.15.8159-8171.2004 Tilgner, 2005, The flavivirus-conserved penta-nucleotide in the 3′ stem–loop of the West Nile virus genome requires a specific sequence and structure for RNA synthesis, but not for viral translation, Virology, 331, 375, 10.1016/j.virol.2004.07.022 Troyer, 2001, A live attenuated recombinant dengue-4 virus vaccine candidate with restricted capacity for dissemination in mosquitoes and lack of transmission from vaccinees to mosquitoes, Am. J. Trop. Med. Hyg., 65, 414, 10.4269/ajtmh.2001.65.414 Westaway, 1997, Ultrastructure of Kunjin virus-infected cells: colocalization of NS1 and NS3 with double-stranded RNA, and of NS2B with NS3, in virus-induced membrane structures, J. Virol., 71, 6650, 10.1128/JVI.71.9.6650-6661.1997 Westaway, 1999, Nascent flavivirus RNA colocalized in situ with double-stranded RNA in stable replication complexes, Virology, 258, 108, 10.1006/viro.1999.9683 Whitehead, 2003, A live, attenuated dengue virus type 1 vaccine candidate with a 30-nucleotide deletion in the 3′ untranslated region is highly attenuated and immunogenic in monkeys, J. Virol., 77, 1653, 10.1128/JVI.77.2.1653-1657.2003 2004 You, 1999, A novel in vitro replication system for Dengue virus. Initiation of RNA synthesis at the 3′-end of exogenous viral RNA templates requires 5′-and 3′-terminal complementary sequence motifs of the viral RNA, J. Biol. Chem., 274, 33714, 10.1074/jbc.274.47.33714 You, 2001, In vitro RNA synthesis from exogenous dengue viral RNA templates requires long range interactions between 5′-and 3′-terminal regions that influence RNA structure, J. Biol. Chem., 276, 15581, 10.1074/jbc.M010923200 Yu, 2005, The topology of bulges in the long stem of the flavivirus 3′ stem–loop is a major determinant of RNA replication competence, J. Virol., 79, 2309, 10.1128/JVI.79.4.2309-2324.2005 Zeng, 1998, Identification of specific nucleotide sequences within the conserved 3′-SL in the dengue type 2 virus genome required for replication, J. Virol., 72, 7510, 10.1128/JVI.72.9.7510-7522.1998